Phenylephrine Pediatric Pharmacokinetic Study

• Status: Completed
• Trial end date: 2008-11-01

Summary

To characterize the pharmacokinetics of phenylephrine in two pediatric populations: children, ages 2 to <12 years, and adolescents, ages 12 to <18 years.

• Phase: Phase 1

Details

• Lead Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide
• Treatments: Nasal Decongestants; Oxymetazoline; Phenylephrine